Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review: Receptor Targeted Nuclear Imaging of Breast Cancer.
Dalm SU, Verzijlbergen JF, De Jong M. Dalm SU, et al. Among authors: verzijlbergen jf. Int J Mol Sci. 2017 Jan 26;18(2):260. doi: 10.3390/ijms18020260. Int J Mol Sci. 2017. PMID: 28134770 Free PMC article. Review.
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
de Koster EJ, van Engen-van Grunsven ACH, Bussink J, Frielink C, de Geus-Oei LF, Kusters B, Peters H, Oyen WJG, Vriens D; EFFECTS trial study group. de Koster EJ, et al. Mol Imaging Biol. 2023 Jun;25(3):483-494. doi: 10.1007/s11307-022-01776-4. Epub 2022 Oct 17. Mol Imaging Biol. 2023. PMID: 36253663 Free PMC article. Clinical Trial.
Skeletal 18F-PSMA-1007 uptake in prostate cancer patients.
Janssen J, Noordzij W, Velleman T, de Jong IJ, Langendijk JA, Verzijlbergen JF, Stormezand GN, Aluwini S. Janssen J, et al. Among authors: verzijlbergen jf. Ther Adv Med Oncol. 2023 Jun 29;15:17588359231179311. doi: 10.1177/17588359231179311. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37441326 Free PMC article.
Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.
Staal FHE, Janssen J, Brouwer CL, Langendijk JA, Ng Wei Siang K, Schuit E, de Jong IJ, Verzijlbergen JF, Smeenk RJ, Aluwini S. Staal FHE, et al. Among authors: verzijlbergen jf. BMC Cancer. 2022 Apr 15;22(1):416. doi: 10.1186/s12885-022-09493-5. BMC Cancer. 2022. PMID: 35428210 Free PMC article.
Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial.
Staal FHE, Siang KNW, Brouwer CL, Janssen J, Budiharto TCG, Haverkort DMAD, Hollmann B, Jacobs I, De Jong MAA, van de Sande MAE, Vanneste BGL, De Jong IJ, Verzijlbergen JF, Langendijk JA, Smeenk RJ, Aluwini S. Staal FHE, et al. Among authors: verzijlbergen jf. Adv Radiat Oncol. 2023 Sep 17;9(2):101379. doi: 10.1016/j.adro.2023.101379. eCollection 2024 Feb. Adv Radiat Oncol. 2023. PMID: 38405312 Free PMC article.
Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline.
Staal FHE, Janssen J, Oprea-Lager DE, Engelen AM, van Limbergen EJ, Smeenk RJ, de Jong MAA, Budiharto TCG, Jacobs I, Haverkort DMAD, Brouwer CL, Ng Wei Siang K, Langendijk JA, Verzijlbergen JF, de Jong IJ, Noordzij W, Aluwini S. Staal FHE, et al. Among authors: verzijlbergen jf. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):688-696. doi: 10.1016/j.ijrobp.2023.09.016. Epub 2023 Sep 18. Int J Radiat Oncol Biol Phys. 2024. PMID: 37729971
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
Privé BM, Janssen MJR, van Oort IM, Muselaers CHJ, Jonker MA, van Gemert WA, de Groot M, Westdorp H, Mehra N, Verzijlbergen JF, Scheenen TWJ, Zámecnik P, Barentsz JO, Gotthardt M, Noordzij W, Vogel WV, Bergman AM, van der Poel HG, Vis AN, Oprea-Lager DE, Gerritsen WR, Witjes JA, Nagarajah J. Privé BM, et al. Among authors: verzijlbergen jf. Trials. 2021 Nov 4;22(1):768. doi: 10.1186/s13063-021-05733-4. Trials. 2021. PMID: 34736509 Free PMC article. Clinical Trial.
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.
Privé BM, Peters SMB, Muselaers CHJ, van Oort IM, Janssen MJR, Sedelaar JPM, Konijnenberg MW, Zámecnik P, Uijen MJM, Schilham MGM, Eek A, Scheenen TWJ, Verzijlbergen JF, Gerritsen WR, Mehra N, Kerkmeijer LGW, Smeenk RJ, Somford DM, van Basten JA, Heskamp S, Barentsz JO, Gotthardt M, Witjes JA, Nagarajah J. Privé BM, et al. Among authors: verzijlbergen jf. Clin Cancer Res. 2021 Jul 1;27(13):3595-3601. doi: 10.1158/1078-0432.CCR-20-4298. Epub 2021 Apr 21. Clin Cancer Res. 2021. PMID: 33883176
71 results